Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma
Sponsor: Mayo Clinic
Summary
This clinical trial tests how well a digital treatment platform using a mobile application works for the delivery of home-based sequential therapy in patients with glioma. Access to specialized neuro-oncology care in the United States for patients with glioma is critically deficient. Care at centers with neuro-oncology specialists is associated with improved survival outcomes, yet many patients have limited access due to distance, disease-related disability, or lack of financial resources. The application provides patients continuous access to their care team in the home setting. A digital treatment platform may increase clinical trial participation and accelerate development of novel therapeutics while addressing a great health disparity in patients with glioma.
Official title: Neuro-Oncology Anywhere: Glioma Home-Based Sequential Therapy (GHoST) Protocol
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-09-12
Completion Date
2028-08-31
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Chemotherapy
Receive standard of care chemotherapy
Computed Tomography
Undergo CT
Internet-Based Intervention
Receive access to the remote chemotherapy management and patient monitoring platform
Magnetic Resonance Imaging
Undergo MRI
Neurologic Examination
Ancillary studies
Questionnaire Administration
Ancillary studies
Surveillance
Undergo surveillance
Locations (2)
Mayo Clinic in Florida
Jacksonville, Florida, United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States